Skip to main content
. 2022 May 17;29(6):1107–1122. doi: 10.1038/s41418-022-01015-x

Fig. 5. The figure shows the SARS-CoV-2 spike protein receptor-binding domain (RBD) bound by class 1/2 (blue), class 3 (orange) and class 4 (green) neutralizing antibodies.

Fig. 5

The potency and breadth of neutralization across SARS-CoV-2 variants are denoted for each antibody class [171–173].